Cargando…

ATRX represses alternative lengthening of telomeres

The unlimited proliferation of cancer cells requires a mechanism to prevent telomere shortening. Alternative Lengthening of Telomeres (ALT) is an homologous recombination-mediated mechanism of telomere elongation used in tumors, including osteosarcomas, soft tissue sarcoma subtypes, and glial brain...

Descripción completa

Detalles Bibliográficos
Autores principales:	Napier, Christine E., Huschtscha, Lily I., Harvey, Adam, Bower, Kylie, Noble, Jane R., Hendrickson, Eric A., Reddel, Roger R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2015
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4599288/ https://www.ncbi.nlm.nih.gov/pubmed/26001292

Ejemplares similares

Alternative lengthening of telomeres is not synonymous with mutations in ATRX/DAXX
por: de Nonneville, Alexandre, et al.
Publicado: (2021)

Loss of Wild-Type ATRX Expression in Somatic Cell Hybrids Segregates with Activation of Alternative Lengthening of Telomeres
por: Bower, Kylie, et al.
Publicado: (2012)

The Role of ATRX in the Alternative Lengthening of Telomeres (ALT) Phenotype
por: Amorim, João P., et al.
Publicado: (2016)

Alternative lengthening of telomeres: remodeling the telomere architecture
por: Conomos, Dimitri, et al.
Publicado: (2013)

Suppression of the alternative lengthening of telomere pathway by the chromatin remodelling factor ATRX
por: Clynes, David, et al.
Publicado: (2015)

Formal reply to “Alternative lengthening of telomeres is not synonymous with mutations in ATRX/DAXX”
por: Feuerbach, Lars
Publicado: (2021)

Loss of ATRX, Genome Instability, and an Altered DNA Damage Response Are Hallmarks of the Alternative Lengthening of Telomeres Pathway
por: Lovejoy, Courtney A., et al.
Publicado: (2012)

Detection of alternative lengthening of telomeres by telomere quantitative PCR
por: Lau, Loretta M. S., et al.
Publicado: (2013)

Telomere elongation involves intra-molecular DNA replication in cells utilizing alternative lengthening of telomeres
por: Muntoni, Alessandra, et al.
Publicado: (2009)

ATRX modulates the escape from a telomere crisis
por: Geiller, Helene E. B., et al.
Publicado: (2022)

A non-genetic switch triggers alternative telomere lengthening and cellular immortalization in ATRX deficient cells
por: Turkalo, Timothy K., et al.
Publicado: (2023)

The macroH2A1.2 histone variant links ATRX loss to alternative telomere lengthening.
por: Kim, Jeongkyu, et al.
Publicado: (2019)

The level of activity of the alternative lengthening of telomeres correlates with patient age in IDH-mutant ATRX-loss-of-expression anaplastic astrocytomas
por: Grandin, Nathalie, et al.
Publicado: (2019)

Synthetic lethality of cytolytic HSV-1 in cancer cells with ATRX and PML deficiency
por: Han, Mingqi, et al.
Publicado: (2019)

Colorectal cancer patient-derived organoids and cell lines harboring ATRX and/or DAXX mutations lack Alternative Lengthening of Telomeres (ALT)
por: Falcinelli, Marta, et al.
Publicado: (2023)

Five dysfunctional telomeres predict onset of senescence in human cells
por: Kaul, Zeenia, et al.
Publicado: (2012)

ATRX loss induces multiple hallmarks of the alternative lengthening of telomeres (ALT) phenotype in human glioma cell lines in a cell line-specific manner
por: Brosnan-Cashman, Jacqueline A., et al.
Publicado: (2018)

Alternative Lengthening of Telomeres and Mediated Telomere Synthesis
por: Hou, Kailong, et al.
Publicado: (2022)

HP1-Mediated Formation of Alternative Lengthening of Telomeres-Associated PML Bodies Requires HIRA but Not ASF1a
por: Jiang, Wei-Qin, et al.
Publicado: (2011)

Alternative Lengthening of Telomeres and Chromatin Status
por: Udroiu, Ion, et al.
Publicado: (2019)

Oncogenic herpesvirus KSHV triggers hallmarks of alternative lengthening of telomeres
por: Lippert, Timothy P., et al.
Publicado: (2021)

The FANCM-BLM-TOP3A-RMI complex suppresses alternative lengthening of telomeres (ALT)
por: Lu, Robert, et al.
Publicado: (2019)

Alternative lengthening of telomeres (ALT) in pediatric high-grade gliomas can occur without ATRX mutation and is enriched in patients with pathogenic germline mismatch repair (MMR) variants
por: Stundon, Jennifer L, et al.
Publicado: (2022)

Non-functional pancreatic neuroendocrine tumours: ATRX/DAXX and alternative lengthening of telomeres (ALT) are prognostically independent from ARX/PDX1 expression and tumour size
por: Hackeng, Wenzel M, et al.
Publicado: (2022)

Alternative Lengthening of Telomeres is characterized by reduced compaction of telomeric chromatin
por: Episkopou, Harikleia, et al.
Publicado: (2014)

Induction of alternative lengthening of telomeres-associated PML bodies by p53/p21 requires HP1 proteins
por: Jiang, Wei-Qin, et al.
Publicado: (2009)

G-quadruplexes mark alternative lengthening of telomeres
por: Yang, Sunny Y, et al.
Publicado: (2021)

Author Correction: The FANCM-BLM-TOP3A-RMI complex suppresses alternative lengthening of telomeres (ALT)
por: Lu, Robert, et al.
Publicado: (2019)

Telomeric replication stress: the beginning and the end for alternative lengthening of telomeres cancers
por: Lu, Robert, et al.
Publicado: (2022)

The alternative lengthening of telomeres mechanism jeopardizes telomere integrity if not properly restricted
por: Silva, Bruno, et al.
Publicado: (2022)

The Molecular Mechanisms and Therapeutic Prospects of Alternative Lengthening of Telomeres (ALT)
por: Sohn, Eric J., et al.
Publicado: (2023)

Pan-Cancer Analysis of Alternative Lengthening of Telomere Activity
por: Sung, Ji-Yong, et al.
Publicado: (2020)

Alternative Lengthening of Telomeres in the Budding Yeast Naumovozyma castellii
por: Cohn, Marita, et al.
Publicado: (2019)

Alternative Lengthening of Telomeres in Pediatric Cancer: Mechanisms to Therapies
por: Kent, Thomas, et al.
Publicado: (2020)

Detection of alternative lengthening of telomeres mechanism on tumor sections
por: Claude, Eloïse, et al.
Publicado: (2021)

Alternative Lengthening of Telomeres Is Rare in Canine Histiocytic Sarcoma
por: Kreilmeier-Berger, Theresa, et al.
Publicado: (2023)

Single-molecule analysis of subtelomeres and telomeres in Alternative Lengthening of Telomeres (ALT) cells
por: Abid, Heba Z., et al.
Publicado: (2020)

RAD52 and SLX4 act nonepistatically to ensure telomere stability during alternative telomere lengthening
por: Verma, Priyanka, et al.
Publicado: (2019)

Alternative lengthening of telomeres (ALT) in cancer stem cells in vivo
por: Bojovic, Bojana, et al.
Publicado: (2014)

SETDB1-dependent heterochromatin stimulates alternative lengthening of telomeres
por: Gauchier, Mathilde, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_fuo79ie2vm2cacupkko4pf2g7f